2021
DOI: 10.1007/s00216-021-03619-7
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant antibodies and their use for food immunoanalysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 46 publications
(25 citation statements)
references
References 148 publications
0
24
0
1
Order By: Relevance
“…Single-chain fragment variables (scFvs) have several advantages over antibodies, including their small size and their ease of production in bacteria (Peltomaa et al, 2022; Weisser and Hall, 2009). We generated a His-tagged scFv based on the sequence of an antibody targeting DLL3 (Methods) ( Figure 2A and Supplementary Figure S2A ).…”
Section: Resultsmentioning
confidence: 99%
“…Single-chain fragment variables (scFvs) have several advantages over antibodies, including their small size and their ease of production in bacteria (Peltomaa et al, 2022; Weisser and Hall, 2009). We generated a His-tagged scFv based on the sequence of an antibody targeting DLL3 (Methods) ( Figure 2A and Supplementary Figure S2A ).…”
Section: Resultsmentioning
confidence: 99%
“…In general, scFv exhibits various advantages, including rapid and inexpensive animal-free production, high potential for improving binding properties, and easy transformation into multispecific molecules to achieve multiple biological effects. Thus, a number of scientists have proposed that scFv can replace traditional animal-derived antibodies; however, others believe that the preparation and application technology of scFv is not mature enough, F I G U R E 1 Basic structure of typical immunoglobulin G (IgG) antibody and scFv antibody and scFv should be used as a supplementary immune reagent, and not as a substitute (Peltomaa et al, 2022). Currently, scFvs are widely used in clinical treatment; however, their application in the field of food safety must be strengthened (Lei et al, 2022).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, the proficient application of phage display technology with the unique advantages of high throughput, high efficiency, short development cycle, and low cost has promoted the single‐chain fragment variable (scFv) to become one of the most widely used recombinant antibody formats (Roth et al., 2021). Compared with other types of recombinant antibodies, scFv maintains the diversity of heavy and light chain binding, high presentation efficiency on the phage surface, and easy expression in most expression systems (Peltomaa et al., 2022). A typical antibody consists of two light chains (∼24 kDa) and two heavy chains (∼55 kDa) linked together by disulfide and noncovalent bonds (Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…With the rapid development of molecular biology research for antibodies, increasingly more genetically engineered antibodies to detect small molecule compounds have been developed [ 18 ]. Recombinant antibodies such as fragment of antigen binding (Fab) and single-chain antibody fragment (ScFv) have been utilized in ELISAs and biosensors [ 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%